Tag: DVT
Inari Medical’s ClotTriever thrombectomy system gains reimbursement approval in Japan
Inari Medical has announced that it received national reimbursement approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for its ClotTriever thrombectomy...
Endologix announces 36-month results of DETOUR2 study
Endologix has announced the final 36-month results from the DETOUR2 study—a prospective, single-arm, international, multicentre clinical evaluation of the novel Detour system for fully...
Novel AI-assisted DVT diagnostic pathway aims to ‘democratize’ point-of-care ultrasound
A new deep vein thrombosis (DVT) diagnostic pathway incorporating non-expert artificial intelligence (AI)-guided compression ultrasound could reduce workload and costs for healthcare systems...
Ensuring the right treatment for patients with PE and DVT
In this short video, Michael Kostrzewa (Baden, Switzerland) and Rashid Akhtar (London, UK) discuss the latest approaches to the treatment of acute pulmonary embolism...
Mechanical thrombectomy shifts the needle toward interventional management of PE and...
This advertorial is sponsored by Inari Medical.
Evaluating the current standard of care for the management of acute pulmonary embolism (PE) and deep vein thrombosis...
First-in-human study of SonoThrombectomy system completed
SonoVascular has announced the successful initiation of its first-in-human study (FIH) of the company's SonoThrombectomy system, an ultrasound-facilitated, thrombolytic-enhanced platform that utilises multiple mechanisms...
Inari Medical updates ClotTriever XL IFU amid US FDA recall notice
The US Food and Drug Administration (FDA) has issued a Class I recall—the most serious type—for Inari Medical's ClotTriever XL, 30mm device due to...
Using “wall-to-wall” mechanical thrombectomy in DVT treatment
Experience wall-to-wall thrombectomy in action with Manuela Konert from Leipzig, Germany! In this brief video, Konert walks through a deep vein thrombosis (DVT) case...
Why treat DVT interventionally with a “wall-to-wall” mechanical thrombectomy approach?
In a recent interview, Marie Josee van Rijn from Rotterdam, the Netherlands and Emma Wilton from Oxford, UK, provided insight into the transformative power...
Computer-assisted vacuum thrombectomy (CAVT) technology broadens patient applicability for complex disease...
NOTE: This video is ONLY available to watch in selected countries and geographies
Consultant interventional radiologist, Andrew Wigham (Oxford, UK) examines his experience with...
One-year CLOUT data demonstrate low rate of PTS following treatment with...
David Dexter (Sentara Vascular Specialists, Norfolk, USA) shared one-year data from the CLOUT registry this week at The VEINS 2023 (28–30 October, Las Vegas,...
How does a lytic-free approach in DVT treatment help in building...
This advertorial is sponsored by Inari Medical.
A recent Inari Medical roundtable webinar examined how to build a venous practice effectively—three experts from different specialties...
ClotTriever “makes fast, safe and efficient thrombectomy possible”
This advertorial is sponsored by Inari Medical
“We need to eliminate symptoms as fast as possible—it is not OK just to make things a little...
Mechanical thrombectomy: ClotTriever offers “extended window” for DVT treatment
This advertorial, sponsored by Inari Medical, is only available in selected countries and geographies.
During a recent webinar hosted by Inari Medical, a multidisciplinary group...
New study demonstrates IVC filters “safe and effective” in treating venous...
Few adverse events are connected to the use of inferior vena cava (IVC) filters to help prevent deep vein blood clots from developing into...
Interventional News’ top 10 most popular stories of January 2023
Interventional News’ most popular stories in the opening month of 2023 included news of first enrolments in clinical studies of peripheral arterial disease (PAD)...
Inari Medical announces first enrolment in DEFIANCE trial evaluating clinical outcomes...
Inari Medical has announced that the first patient has been enrolled in DEFIANCE, a prospective randomised controlled trial (RCT) comparing the clinical outcomes of...
Interventional News’ top 10 most popular stories of November 2022
Interventional News’ most popular stories last month included news of a US Food and Drug Administration pre-market approval submission of an ultrasound renal denervation...
SIR deems endovascular management acceptable treatment option for certain iliofemoral DVT...
The Society of Interventional Radiology (SIR) published a position statement deeming endovascular thrombus removal “an acceptable treatment option in selected patients with acute iliofemoral...
Mechanical thrombectomy for DVT: Randomised data needed to boost growing evidence...
Two datasets presented during the late-breaking clinical trials session at The VEINS (Venous Endovascular Interventional Strategies) 2022 (30–31 October, Las Vegas, USA)—the latest results...
New mechanical thrombectomy systems unlock possibilities for the treatment of venous...
Gerd Grözinger (Tübingen, Germany) chats with Bernhard Gebauer (Berlin, Germany) at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2022 annual meeting (10–14...
Interventional News’ top 10 most popular items of September 2022
Interventional News’ most popular content last month included news of the acquisition of a new catheter by Bentley, the announcement of the final patient...
ClotTriever deemed a “game-changer” in deep vein thrombosis treatment
This advertorial, sponsored by Inari Medical, is only available in selected countries and geographies.
“I am finally very confident I have a device that...
Why ClotTriever is a “gamechanger” for the treatment of deep vein...
Andrew Wigham (Oxford, UK) and Rick De Graaf (Friedrichshafen, Germany) discuss the current state of deep vein thrombosis (DVT) treatment at the Leipzig Interventional...
Inari Medical announces randomised controlled trial evaluating clinical outcomes of the...
Inari Medical has announced planned enrolment of the DEFIANCE randomised controlled trial (RCT), which is designed to compare the clinical outcomes of patients with...
Study finds increased risk of serious blood clots up to six...
A study from Sweden published by The BMJ recently finds an increased risk of deep vein thrombosis (DVT) up to three months after COVID-19 infection,...
Cordis makes strategic investment in E2, a developer of next-generation thrombectomy...
Cordis has announced a strategic investment venture that will expand the scope of the global cardiovascular technology company into the venous thromboembolism (VTE) market...
Cardiovascular Systems partners with Innova Vascular to develop full line of...
Cardiovascular Systems Inc (CSI) recently announced it has partnered with Innova Vascular (Innova) to develop a full line of novel thrombectomy devices.
According to a...
AVF 2022: Emerging autogenous venous valve formation system sees “continual improvement”
An emerging endovenous valve formation system designed to treat patients with chronic venous insufficiency (CVI) with evidence of deep venous reflux has demonstrated continual...
Thrombus dissolution with EKOS™ Acoustic Pulse Thrombolysis™ in everyday clinical practice
At the EKOS symposium at LINC 2019, Nils Kucher (Zurich, Switzerland), Houman Jalaie (Aachen, Germany) and Mert Dumantepe (Istanbul, Turkey) share their experiences in...
New DVT device completes first-in-human trial
The first-in-human case using the new deep vein thrombosis (DVT) device Vetex thrombectomy catheter (Vetex Medical) has recently been completed in a multicentre study....
New developments in treatment of deep venous thrombosis
An analysis ATTRACT has just been published in the journal, Circulation in which the authors examine the effect of pharmacomechanical catheter-directed therapy (PCDT) in ATTRACT...
New ATTRACT data show catheter-based therapy significantly reduces leg symptoms and...
A new study, recently published online in the journal Circulation, reports on outcomes from a subgroup of 391 patients with acute iliofemoral deep venous...
New products showcased at SIR 2018
There were several devices in the New Product Showcase at the Society of Interventional Radiology's Annual Scientific Meeting in Los Angeles, USA. Among these...
ACCESS PTS study demonstrates Ekos’ efficacy in treatment of post-thrombotic syndrome
BTG has highlighted the results of the ACCESS PTS trial, presented at the Society for Vascular Medicine 28th annual scientific sessions (14–17 June, New...
ATTRACT fails to meet primary endpoint, but experts agree results are...
Data from the randomised controlled ATTRACT trial revealed that the addition of catheter-based intervention to standard-of-care anticoagulation failed to significantly decrease the occurrence of...
ATTRACT trial results to be presented at SIR 2017 meeting
Suresh Vedantham, professor of Radiology and Surgery, Mallinckrodt Institute of Radiology, Washington University School of Medicine in St Louis, USA, is scheduled to present the...
BTG receives US FDA 510(k) clearance for Ekos control unit 4.0
BTG has announced that US FDA 510(k) clearance has been granted to the Ekos control unit 4.0.
The Ekos system includes an ultrasonic device...
First pulmonary embolism patients in Hong Kong treated with the BTG’s...
The first Hong Kong-based patients diagnosed with pulmonary embolism have been treated using the newly available BTG EKOS system. The EKOS system includes an...
